Journal profile · Medicine-Neurology (clinical)
CNS oncology
ISSN 2045-0915 · Future Medicine Ltd. · United Kingdom
CNS oncology: fully open access; APC about USD 1,800; median 175 days to acceptance (14 articles, last 24 months); acceptance rate 50% (journal website); 5 articles in 2025; indexed in Scopus; the journal's website says submissions are paused or closed.
The journal's website says submissions are paused or closed: CNS Oncology is no longer accepting submissions. Our in-house Commissiong Editors will be in contact with authors with submissions currently under review. All published content to date will remain available online. For prospective submissions, please reach out to Publisher Sophie Aves (Sophie.Aves@tandf.co.uk), who will be able to suggest suitable alternative journals for your content. Source ↗Publisher website ·
Scope
Aims, scope and focus
CNS oncology is published by Future Medicine Ltd.. By OpenAlex counts of its recent articles, its largest topics are Glioma Diagnosis and Treatment, Brain Metastases and Treatment and Cancer survivorship and care, together about 53.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
CNS Oncology is no longer accepting submissions. Our in-house Commissiong Editors will be in contact with authors with submissions currently under review. All published content to date will remain available online. For prospective submissions, please reach out to Publisher Sophie Aves ( Sophie.Aves@tandf.co.uk), who will be able to suggest suitable alternative journals for your content. CNS Oncology addresses key issues and current understanding in the diagnosis, staging and treatment of disease by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. CNS Oncology provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances in clinical practice in the field are reported and analyzed by international experts, and the importance of the most recent advances in molecular biology are explained. High-quality, methodologically sound papers are considered in the following areas: Diagnosis and imaging Staging Epidemiology Case reports/case series Patient perspectives Pharmacoeconomics and outcomes research Pathology Palliative Care Radiotherapy Chemotherapy Surgical approaches Systemic therapies Adjuvant therapy Biomarkers Clinical trials – protocols and updates Comparative effectiveness Molecular biology of disease Molecular diagnostics Risk and prevention The journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Neurology (clinical)
Editorial board by country: none in mainland China; most named United States 2, United Kingdom 1, Singapore 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glioma Diagnosis and TreatmentMedicine37.5%
- Brain Metastases and TreatmentMedicine11.6%
- Cancer survivorship and careMedicine4.5%
- Management of metastatic bone diseaseMedicine4.4%
- Ovarian cancer diagnosis and treatmentMedicine4.3%
- Meningioma and schwannoma managementMedicine4.2%
- Acute Myeloid Leukemia ResearchMedicine2.5%
- CNS Lymphoma Diagnosis and TreatmentMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Neurology (clinical) | Q2 | 132/403 | 67th |
| Neurology | Q2 | 72/201 | 64th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Index Medicus
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher) 2025
- 5Publisher website ·
- SJR 2026-06
- 0.99LetPub ·
- SJR (publisher) 2025
- 0.99Publisher website ·
- SNIP 2026-06
- 0.85LetPub ·
- SNIP (publisher) 2025
- 0.85Publisher website ·
- h-index
- 42OpenAlex ·
- i10-index
- 184OpenAlex ·
- 2-year mean citedness
- 3.3OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher)
- 68,000Publisher website ·
Articles by year OpenAlex count · 413 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 7 | 7 | 533 |
| 2025 | 5 | 5 | 845 |
| 2024 | 15 | 15 | 846 |
| 2023 | 13 | 13 | 796 |
| 2022 | 13 | 13 | 917 |
| 2021 | 12 | 12 | 828 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
175 daysMedian, submission to acceptance · P25–P75 116 days – 248 days
- Acceptance to online
- median 17 days (14 articles)
- Submission to online
- median 188 days
- Sample
- 14 articles with submission and acceptance dates (14 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Acceptance rate (publisher)
- 50%Publisher website ·
- Submission to first decision
- 70 daysPublisher website ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,800 | Yes | CC BY-NC | |
| OpenAlex | USD 1,415 | — | — | |
| LetPub | USD 1,415 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- narrative reviewThe journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces.Length not stated
- opinion pieceThe journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces.Length not stated
- original researchThe journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces.Length not stated
- systematic reviewThe journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces.Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Open access journal; only publishes open access articles. Model summary
CNS Oncology is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, not just those with easy …
Source ↗Publisher website ·- Peer review
Journal no longer accepting submissions Model summary
CNS Oncology is no longer accepting submissions.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Future Medicine Ltd.
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2045-0915
- Print ISSN
- 2045-0907
- Latest issue on the website
- Volume 15, Issue 1 (2026)
- Official links
FAQ
Frequently asked questions about CNS oncology
How long does peer review take at CNS oncology?
Based on the dates recorded on 14 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 175 days (interquartile range 116–248 days); authors report an average review time of about 13 weeks; the journal's website gives an acceptance rate of 50%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of CNS oncology based?
Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (2), United Kingdom (1) and Singapore (1). Counted from the institutions listed on the board page; for reference only.
Which databases index CNS oncology?
According to LetPub and DOAJ records, CNS oncology is indexed in Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is CNS oncology open access, and what is the APC?
CNS oncology is a fully open-access journal. APC about USD 1,800.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .